Balyasny Asset Management LLC Maravai Lifesciences Holdings, Inc. Transaction History
Balyasny Asset Management LLC
- $54.9 Billion
- Q2 2024
A detailed history of Balyasny Asset Management LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 53,438 shares of MRVI stock, worth $449,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,438
Previous 486,205
89.01%
Holding current value
$449,947
Previous $4.22 Million
90.94%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding MRVI
# of Institutions
221Shares Held
124MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$111 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$90.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$81.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$76 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$50.3 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $1.11B
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...